Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma
Clinical trial NCT02320292 · TERMINATED
Trial details
- NCT number
- NCT02320292
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-11
- Primary completion
- 2021-02-28
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.